Stem Cell Therapy in Autoimmune Diseases
Biomarkers, represented by genetically determined traits or biologic changes predictive of disease onset or outcome, are increasingly employed by academic and industrial investigators. They can identify unusually susceptible populations or individuals, facilitate prognosis, Currently, autoimmune conditions are treated with immune suppressive agents such as steroids, methothrexate, cyclosporine, gold, and more recently infliximab (Remicade).
- Hematopoietic Stem Cell Therapy for Autoimmune Diseases
- Development of Hematopoietic Stem Cell Lines for Transplantation
- Gene Therapy and Stem Cell Approaches for the Treatment of Autoimmune Diseases
Related Conference of Stem Cell Therapy in Autoimmune Diseases
December 21-22, 2026
7th World Congress on Neuroimmunology and Neuroinfectious Diseases
Paris, France
March 15-16, 2027
22nd International Conference on Allergic Diseases and Clinical Immunology
Paris, France
March 22-23, 2027
14th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
London, UK
Stem Cell Therapy in Autoimmune Diseases Conference Speakers
Recommended Sessions
- Autoimmune Diseases
- Cancer and Autoimmunity
- Complement in Autoimmunity
- Genetics and Epigenetics
- Infection and Autoimmunity
- Low Dose Naltrexone & Autoimmune Conditions
- Molecular Immunology
- New Cytokines and Anti-Cytokines
- Novel Therapeutic Targets
- Peptides and Autoimmune Diseases
- Prediction, Monitoring and Prevention
- Stem Cell Therapy in Autoimmune Diseases
- Therapy of Autoimmune Liver Disease
- Thyroid Autoimmunity
- Translational Immunology
Related Journals
Are you interested in
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (France)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (France)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (France)